Clinical trial
Evaluation of Safety and Efficacy of Intrastromal Implantation of CorVision® Bioengineered Corneal Inlay for Correction of Presbyopia.
NCT04465409 is registered in ClinicalTrials.gov with LinkoCare Life Sciences AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety and Efficacy of Intrastromal Implantation of CorVision® Bioengineered Corneal Inlay for Correction of Presbyopia.
- Lead sponsor
- LinkoCare Life Sciences AB
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 25, 2020
- Completion date
- June 30, 2026
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.